Literature DB >> 31009138

miR-188-5p emerges as an oncomiRNA to promote gastric cancer cell proliferation and migration via upregulation of SALL4.

Mei Wang1, Rong Qiu1, Zheng Gong1, Xinxin Zhao1, Tingting Wang1, Lulu Zhou1, Weiwei Lu1, Bo Shen2, Wei Zhu1, Wenrong Xu1.   

Abstract

MicroRNAs (miRNAs) play pivotal roles in modulating key biological processes in gastric cancer (GC). As a newly identified miRNA, the function and potential mechanism of miR-188-5p in GC has not been thoroughly elucidated. Here, quantitative real-time polymerase chain reaction detection showed abnormally higher expression of miR-188-5p in GC cells and tissues. Gain-of-function analysis in vitro showed that miR-188-5p promoted GC cell proliferation and migration, while loss-of-function studies showed the reverse. Targetscan has predicted that phosphatase and tensin homolog (PTEN) was a potential target gene of miR-188-5p. miR-188-5p suppressed PTEN messenger RNA and protein expression and activated downstream AKT/mTOR signaling in GC cells, but luciferase reporter analysis showed that PTEN was not regulated by miR-188-5p via the 3' untranslated region. Furthermore, we observed that miR-188-5p overexpression promoted Sal-like protein 4 (SALL4) protein expression, cellular nuclear translocation, and transcription. Knockdown of SALL4 eliminated the effect of miR-188-5p in GC cells as well as suppression of PTEN. Taken together, our results demonstrate that miR-188-5p promotes GC cell proliferation and migration while suppressing tumor suppressor gene PTEN expression via transcriptional upregulation of oncogene SALL4. We conclude that miR-188-5p acts as an oncomiRNA in GC and may be a promising therapeutic target for GC.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Sal-like protein 4; gastric cancer; miR-188-5p; migration; phosphatase and tensin homolog; proliferation

Year:  2019        PMID: 31009138     DOI: 10.1002/jcb.28764

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

1.  LncRNA GNAS-AS1 knockdown inhibits keloid cells growth by mediating the miR-188-5p/RUNX2 axis.

Authors:  Yun Liu; Lei Li; Jia-Yao Wang; Fei Gao; Xia Lin; Shi-Shuai Lin; Zhi-Yang Qiu; Zun-Hong Liang
Journal:  Mol Cell Biochem       Date:  2022-08-29       Impact factor: 3.842

2.  Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway.

Authors:  Xianglan Yi; Liping Lou; Jun Wang; Jing Xiong; Sheng Zhou
Journal:  Cancer Chemother Pharmacol       Date:  2021-02-05       Impact factor: 3.333

3.  MicroRNA‑188‑5p inhibits the progression of breast cancer by targeting zinc finger protein 91.

Authors:  Zhiguang Yang; Zhaoyu Liu; Zhihui Chang; Guangxin Yan
Journal:  Oncol Rep       Date:  2020-08-12       Impact factor: 3.906

4.  miR-335-5p suppresses gastric cancer progression by targeting MAPK10.

Authors:  Yi Gao; Yanfeng Wang; Xiaofei Wang; Changan Zhao; Fenghui Wang; Juan Du; Huahua Zhang; Haiyan Shi; Yun Feng; Dan Li; Jing Yan; Yan Yao; Weihong Hu; Ruxin Ding; Mengjie Zhang; Lumin Wang; Chen Huang; Jing Zhang
Journal:  Cancer Cell Int       Date:  2021-01-22       Impact factor: 5.722

5.  Silencing SALL-4 Gene by Transfecting Small Interfering RNA with Targeted Aminoglycoside-Carboxyalkyl Polyethylenimine Nano-Polyplexes Reduced Migration of MCF-7 Breast Cancer Cells.

Authors:  Somaye Noruzi; Mehran Vatanchian; Amir Azimian; Arash Niroomand; Reza Salarinia; Fatemeh Oroojalian
Journal:  Avicenna J Med Biotechnol       Date:  2021 Jan-Mar

6.  MicroRNA Alterations Induced in Human Skin by Diesel Fumes, Ozone, and UV Radiation.

Authors:  Giuseppe Valacchi; Erika Pambianchi; Simona Coco; Alessandra Pulliero; Alberto Izzotti
Journal:  J Pers Med       Date:  2022-01-28

Review 7.  SALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance.

Authors:  Boshu Sun; Liangliang Xu; Wenhui Bi; Wen-Bin Ou
Journal:  Int J Mol Sci       Date:  2022-02-12       Impact factor: 5.923

8.  The Relationship between Pre-miR-3131 3-bp Insertion/Deletion Polymorphism and Susceptibility and Clinicopathological Characteristics of Patients with Breast Cancer.

Authors:  Mahsa Azizi; Nahid Rahimi; Gholamreza Bahari; Seyed Mehdi Hashemi; Mohammad Hashemi
Journal:  Microrna       Date:  2020

9.  SALL4 and microRNA: The Role of Let-7.

Authors:  Jun Liu; Madeline A Sauer; Shaza G Hussein; Junyu Yang; Daniel G Tenen; Li Chai
Journal:  Genes (Basel)       Date:  2021-08-24       Impact factor: 4.096

Review 10.  SALL Proteins; Common and Antagonistic Roles in Cancer.

Authors:  Claudia Álvarez; Aracelly Quiroz; Diego Benítez-Riquelme; Elizabeth Riffo; Ariel F Castro; Roxana Pincheira
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.